Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
72%
OVERLAP
BY WEIGHT
59
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
100%
ALSO IN IXJ
IXJ
114
HOLDINGS
56%
ALSO IN XLV
SECTOR DRIFT (XLV minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 16.1% | 10.8% | 10.8% | |
| JOHNSON & JOHNSON | 10.8% | 7.3% | 7.3% | |
| ABBVIE INC | 7.8% | 5.2% | 5.2% | |
| UNITEDHEALTH GROUP INC | 6.5% | 4.4% | 4.4% | |
| MERCK & CO. INC. | 5.5% | 4.2% | 4.2% | |
XLV Overweight Relative to IXJ
| ELI LILLY & CO | 5.3% | |
| JOHNSON & JOHNSON | 3.5% | |
| ABBVIE INC | 2.6% | |
| UNITEDHEALTH GROUP INC | 2.1% | |
| MERCK & CO. INC. | 1.3% | |
| THERMO FISHER SCIENTIFIC INC | 0.9% | |
| AMGEN INC | 0.8% | |
| ABBOTT LABORATORIES | 0.7% | |
| GILEAD SCIENCES INC | 0.7% | |
| PFIZER INC | 0.6% |
XLV Underweight Relative to IXJ
| NOVARTIS AG | -3.6% | |
| ASTRAZENECA PLC | -3.4% | |
| NOVO NORDISK A/S-B | -2.0% | |
| GSK PLC | -1.3% | |
| SANOFI-AVENTIS | -1.2% | |
| ARGEN-X SE | -0.7% | |
| TAKEDA PHARMACEUTICAL CO LTD | -0.7% | |
| ESSILOR INTERNATIONAL | -0.7% | |
| BAYER AG | -0.7% | |
| HOYA CORP | -0.6% |